Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)

    Limited submission

    NIH's limited competition supports institutions in historically underfunded states to build biomedical research capacity through early-career recruitment, mentoring, facilities, and administrative support.

    Browse similar grants
    Limited Submission Grant Opportunities
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: National Institutes of Health

    Due Dates: January 25, 2027 (Application) | May 25, 2027 (Application) | September 25, 2027 (Application) | January 25, 2028 (Application) | May 25, 2028 (Application) | September 25, 2028 (Application) | January 25, 2029 (Application) | May 25, 2029 (Application) | May 26, 2029 (Closing)

    Funding Amounts: Up to $400,000 direct costs in year 1 and $1.8 million annually in years 2–5; maximum five years

    Summary: Builds biomedical research capacity at less-resourced institutions in IDeA jurisdictions through faculty recruitment, mentoring, facilities, and research administration.

    Key Information: Institutions must have no active COBRE grants at submission, including grants in no-cost extension.


    Description

    The Centers of Biomedical Research Excellence Development Phase (COBRE-D) is a limited-competition P30 program administered by the National Institute of General Medical Sciences (NIGMS) within NIH’s Institutional Development Award (IDeA) program. It supports institutions in jurisdictions that historically received low levels of NIH funding, targeting broad biomedical scientific areas of strategic institutional importance where infrastructure and investigator expertise are lacking.

    Awards support recruitment and mentoring of three to six early- to mid-career investigators, supplemental start-up packages, research facilities, and stronger research administration. An initial ramp-up period of up to 12 months establishes the organizational framework. COBRE-D is an on-ramp to the COBRE Expansion and Sustainability phases, rather than support for an already-developed research area. Clinical trials are not allowed, although human-subjects activities that are not clinical trials may be proposed.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.